Introduction As long as syndromic management of sexually transmitted infections (STI) remains the main model of care in low and middle income countries, diagnostic surveillance is essential for STI control, especially in high HIV incidence settings. Here, we present the baseline data from the CAPRISA 083 cohort study that was conducted in a large urban primary health care clinic in KwaZulu-Natal, South Africa. Methods Women aged 18-40 presenting for syndromic STI care at the facility were assessed for participation. HIV positive women (prevalence 39.1%), pregnant women (9.1%) or those engaging in sex work were excluded due to pre-determined eligibility criteria. Women consenting to the study completed a sexual risk questionnaire, were examined by a nurse, and underwent point-of-care testing for chlamydia and gonorrhoea (Xpert CT/NG), trichomonas (OSOM rapid test), and microscopy to assess for bacterial vaginosis (BV) and candida.
Gonorrhoea cases were further investigated for antibiotic resistance. Results A total of 267 women, median age 23 (IQR 21-27), were enrolled and 88.4% reported to be symptomatic. All were sexually active and 75.7% stated that they used condoms with their partners, although only 3.7% used them consistently. 125 (46.8%) had abnormal pelvic examinations, including 106 (39.7%) women with vaginal discharge. STI testing revealed an 18.5% prevalence of chlamydia (20.5% in <25 year-olds), 5.2% gonorrhoea and 2.6% trichomonas. Two thirds of women (69.3%) had evidence of abnormal vaginal flora (33.7% BV and 35.6% intermediate flora) based on Nugent Score, and 17.6% were diagnosed with candida infection. A total of 52/267 (19.5%) reported symptoms, but had no STI or abnormal flora found. Of 9 specimen cultured for gonorrhoea resistance, 7 (77.7%) were resistant to penicillin and 4 (44.4%) to ciprofloxacin, but no cephalosporin resistance was identified. Conclusion In this high HIV incidence setting, the burden of chlamydia infection and abnormal vaginal flora was concernedly high, warranting enhanced STI management strategies at population level. Support: This work was NIH-funded (AI116759). Cepheid loaned two 4-module Genexpert machines to the study team free-of-charge, but did not contribute to the preparation of this abstract Introduction Chlamydia trachomatis (Ct) genital infection is the most commonly reported bacterial infection in the United States (US). High-risk groups include women<25 years. Untreated infections may lead to pelvic inflammatory disease and infertility. Most infections are asymptomatic, so screening high-risk women is important. The US National Commission on Prevention Priorities ranked annual Ct screening of sexually active women as one of the top 10 prevention strategies. The Army screens women <25 yearly, and Ct is reportable. Ct incidence dropped from 2011 ((109/1000 person-years (py)) to 2012 (86/1000 py). A search for artifactual contributions found the proportion of specimens submitted that tested positive remained stable, but screening rates dropped. Subsequently, screening rates improved. During 2012-2014, the reported Ct annual incidence stabilised, averaging 86/1000 py. However, Ct incidence for 2015 increased to 92/1000 py, prompting another review of the relationship between reported Ct incidence and screening rates. Methods Incidence rates were compiled from Ct reports in non-deployed Soldiers submitted to the military Disease Reporting System-internet. Screening rates were obtained from the Military Health System Population Health Portal. To deal with variations in screening, modelled incidence projections were developed to reflect a theoretical 100% screening compliance.
Results Incidence projections confirmed a decrease in the 2011-2014 modelled incidence/1000 py: 2011-129,
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